NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

40B buyout seems low considering the above

why? did NWBO just release data proving DCVAX works for all solid tumors independent of what the cancer indications are? Im pretty sure Gilead won't be thrilled its 21$ billion investment in acquiring Immunomedics will be swiped away by a drug that has not been proven efficient for, for example, adult patients with metastatic triple-negative breast cancer. Im also pretty sure Gilead will sue the hell out of the FDA if NWBO/DCVAX were to be granted approval for solid tumor breast without medical trials.

So please tell me why the total market for solid tumors is relevant if NWBO has not proven any efficiency outside any other indication other than GBM? Ooh the potential but all platforms claim future potential so does TrodelvyTM First-in-Class Antibody-Drug Conjugate Approved to Treat Triple-Negative Breast Cancer, With Promise in Other Forms of Breast Cancer and Additional Solid Tumors, yet Gilead paid $21 billion for Immunomedics.

Until the data is in DCVAX is effective for multi-cancer indications, DCVAX its worth what GBM treatment will generate so roughly the same as breast cancer indication wich is $21 billion

https://www.gilead.com/news-and-press/press-room/press-releases/2020/9/gilead-sciences-to-acquire-immunomedics